Validation of Next Generation Sequencing-Based Clonality Assays for Diagnosis and Minimal Residual Disease Tracking in Lymphoid Malignancies

被引：0
|
作者：
Wu, Haiyan [1 ]
Li, Feng [1 ]
Cai, Jiacheng [1 ]
Zhang, Ke [1 ]
Zheng, Xin [1 ]
Yao, Jicheng [1 ]
Wang, Weifeng [1 ]
Wang, Kai [1 ]
机构：
[1] OrigiMed Co Ltd, Shanghai, Peoples R China
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-150151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Clinical validation of next-generation sequencing-based clonality assays for minimal residual disease tracking in multiple myeloma
    Lin, Chuanming
    Jian, Qijie
    Huang, Zoufang
    Xie, Shuiling
    Xin, Liuyan
    Wu, Haiyan
    Pang, Fei
    Liao, Changfeng
    Chen, Yijian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Analytical Validation of a Next-Generation Sequencing Assay for Detecting Minimal Residual Disease in Lymphoid Malignancies
    Zhou, Yiwei
    Ma, Zhiyuan
    Huang, Shiang
    Li, Zhenhui
    Lei, Beining
    Zou, Fang
    Li, Qijiao
    Liang, Liang
    Sun, Li
    Zhang, Jie
    BLOOD, 2024, 144 : 4972 - 4973
  • [3] Next generation sequencing-based monitoring for minimal residual disease in acute myeloid leukemia
    Ok, Chi Young
    Salim, Alaa
    Luthra, Rajyalakshmi
    Patel, Keyur
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S196 - S196
  • [4] Comparison of Next-Generation Sequencing-Based TRG and TRB Assays for the Diagnostic Evaluation of T Cell Lymphoid Malignancies
    Ho, C.
    Tung, J.
    Zehnder, J.
    Zhang, B.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S16 - S16
  • [5] Development and validation of a clinical next generation sequencing-based assay for hematologic malignancies
    Lipson, Doron
    Nahas, Michelle K.
    Otto, Geoff A.
    He, Jie
    Wang, Kai
    Knapp, Kristina M.
    Brennan, Kristina W.
    Donahue, Amy L.
    Young, Lauren E.
    Young, Geneva
    Fichtenholtz, Alex
    Ross, Jeffrey S.
    Yelensky, Roman
    Stephens, Philip J.
    Miller, Vincent A.
    Levine, Ross
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies
    Sanchez, Ricardo
    Ayala, Rosa
    Martinez-Lopez, Joaquin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)
  • [7] Clinical Utility of Next-Generation Sequencing-Based Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
    Sekiya, Yuko
    Okuno, Yusuke
    Muramatsu, Hideki
    Narita, Atsushi
    Suzuki, Kyogo
    Wang, Xinan
    Kawashima, Nozomu
    Xu, Yinyan
    Sakaguchi, Hirotoshi
    Yoshida, Nao
    Hama, Asahito
    Takahashi, Yoshiyuki
    Kato, Koji
    Kojima, Seiji
    BLOOD, 2015, 126 (23)
  • [8] Detection of clonality and minimal residual disease monitoring in childhood lymphoid malignancies in the Czech Republic
    Zuna, J
    Hrusák, O
    Soukup, J
    Kalinová, M
    Muziková, K
    Sedláková, K
    Kodet, R
    Stary, J
    Trka, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 233 - 233
  • [9] Sequencing-Based Detection of Minimal Residual Disease Is Associated with Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Lymphoid Malignancies
    Herrera, Alex F.
    Kim, Haesook T.
    Faham, Malek
    Sun, Heather
    Sohani, Aliyah R.
    Alyea, Edwin P.
    Chen, Yi-Bin
    Cutler, Corey S.
    Ho, Vincent T.
    Koreth, John
    Nikiforow, Sarah
    Ritz, Jerome
    Rodig, Scott J.
    Soiffer, Robert J.
    Antin, Joseph H.
    Armand, Philippe
    BLOOD, 2014, 124 (21)
  • [10] Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia
    Mai, Huirong
    Li, Qin
    Wang, Guobing
    Wang, Ying
    Liu, Shilin
    Tang, Xue
    Chen, Fen
    Zhou, Guichi
    Liu, Yi
    Li, Tonghui
    Wang, Lulu
    Wang, Chunyan
    Wen, Feiqiu
    Liu, Sixi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3259 - 3266
12345